Skip to main content
43°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger, Inc. - Common Stock
(NQ:
SDGR
)
21.93
-0.84 (-3.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Schrodinger, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Earnings Outlook For Schrodinger
May 03, 2023
Via
Benzinga
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
April 27, 2023
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...
Via
Talk Markets
Schrödinger Publishes Inaugural Corporate Sustainability Report
April 27, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce First Quarter 2023 Financial Results on May 4
April 20, 2023
From
Schrödinger
Via
Business Wire
Analyst Expectations for Schrodinger's Future
March 10, 2023
Via
Benzinga
Why Shares of Schrödinger Were Up Today
March 01, 2023
The company delivered a nice earnings surprise.
Via
The Motley Fool
Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know
January 31, 2023
Via
Benzinga
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 19, 2023
From
Schrödinger, Inc.
Via
Business Wire
The C3.ai Stock Debate: Overpriced or Underestimated?
April 16, 2023
The valuation of AI stock was attractive many months ago, but at this point their price-sales ratio has become quite elevated.
Via
InvestorPlace
3 Industries Set to Be Transformed by the AI Revolution
April 16, 2023
AI will allow companies in many sectors to save a great deal of money and tremendously increase their revenue.
Via
InvestorPlace
The 3 Best AI Stocks to Buy Right Now
April 14, 2023
Here are the best AI stocks to buy now as companies look to harness the power of this disruptive technology.
Via
InvestorPlace
3 Tech Stocks to Buy for the Fourth Industrial Revolution
March 25, 2023
These companies all utilize multiple technologies that are part of the Fourth Industrial Revolution, making them great tech stocks to buy.
Via
InvestorPlace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 22, 2023
From
Schrödinger, Inc.
Via
Business Wire
Evogene Offers An Excellent Risk/Reward Ratio
March 21, 2023
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...
Via
Talk Markets
Not Quite a Bailout: So Much Banking News to Discuss
March 16, 2023
Plus, two Motley Fool analysts share their insight on a pair of stocks to watch.
Via
The Motley Fool
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
MarketBeat Week in Review – 3/6 - 3/10
March 11, 2023
Stocks are down sharply to end the week, and the MarketBeat staff continues to show investors why dividend stocks need to be part of your playbook
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Interest Rates
3 Amazing AI Stocks for Your March Buy List
March 09, 2023
With the Street catching onto the transformational power of AI, these amazing AI stocks are very well-positioned to climb tremendously.
Via
InvestorPlace
Schrodinger is an AI-Powered Drug Discovery Developer to Watch
March 08, 2023
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 01, 2023
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via
Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
March 01, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Via
Benzinga
Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results
February 28, 2023
From
Schrödinger, Inc.
Via
Business Wire
3 AI Stocks to Buy for the Future of Automation
February 17, 2023
Increased appreciation for AI and the Street's reduced hostility to growth stocks make this a good time to find AI stocks to buy.
Via
InvestorPlace
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda
February 14, 2023
From
Schrödinger Inc.
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28
February 13, 2023
From
Schrödinger
Via
Business Wire
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
February 04, 2023
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a...
Via
Talk Markets
Schrödinger to Present at SVB Securities Global Biopharma Conference
January 31, 2023
From
Schrödinger
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.